- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- January 2026
- 60 Pages
Global
From €1128EUR$1,250USD£980GBP
- Report
- June 2025
- 150 Pages
Global
From €3384EUR$3,750USD£2,940GBP
- Report
- March 2026
- 371 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- January 2026
- 181 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 180 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 185 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 182 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 181 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 181 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 180 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 181 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 181 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 180 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 182 Pages
Global
From €4061EUR$4,500USD£3,528GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more